Clinical Trials Browser

Observational × atezolizumab × Genitourinary × Clear all

NCT03782207 2026-01-08

IMreal

Active not recruiting

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma

NCT05287464 2025-11-26

International Multicentric Study ARON-1

Carcinoma, Renal Cell

NCT06169904 2023-12-14

B7-Family Score in Urothelial Carcinoma

Carcinoma, Transitional Cell

NCT03330886 2023-03-13

A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina

Carcinoma, Transitional Cell

NCT04107168 2023-02-16

Microbiome Immunotherapy Toxicity and Response Evaluation

DermatologicGenitourinaryThoracic

Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT03232593 2022-08-24

A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

BreastGastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03399643 2019-04-19

Announce

Carcinoma, Transitional Cell